Stockreport

BeyondSpring plinabulin, Merck Keytruda combo shows promise in NSCLC [Seeking Alpha]

BeyondSpring, Inc. - Ordinary Shares  (BYSI) 
Last beyondspring, inc. - ordinary shares earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.beyondspringpharma.com
PDF results as a treatment for non-small cell lung cancer after failure on a checkpoint inhibitor. Interim data from the single-arm, open-label phase 2 Study 303 based on [Read more]